Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.70 is 57% below its 5-year average of 18.00, near the low end of its 5-year range (7.70–43.05).
As of the fiscal period ended Tuesday, June 30, 2026. 26.25% below its 12-month average of 10.45.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.70.
QUICK RATIO (ACID-TEST)
7.70
QUICK RATIO (ACID-TEST) AVG TTM
10.45
QUICK RATIO (ACID-TEST) AVG 3Y
13.98
QUICK RATIO (ACID-TEST) AVG 5Y
18.00
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-26.25%
CURRENT VS 3Y AVG
-44.91%
CURRENT VS 5Y AVG
-57.21%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+129.61%
vs the sector median at left
PMV Pharmaceuticals, Inc.
Market Cap
$85.86M
Quick Ratio (Acid-Test)
7.70
TTM Avg
10.45
3Y Avg
13.98
5Y Avg
18.00
Market Cap
$87.27M
Quick Ratio (Acid-Test)
4.50
TTM Avg
8.19
3Y Avg
12.95
5Y Avg
15.06
Market Cap
$84.13M
Quick Ratio (Acid-Test)
7.03
TTM Avg
3.05
3Y Avg
3.90
5Y Avg
4.20
Market Cap
$87.85M
Quick Ratio (Acid-Test)
1.98
TTM Avg
0.61
3Y Avg
1.40
5Y Avg
2.59
Market Cap
$87.96M
Quick Ratio (Acid-Test)
1.01
TTM Avg
1.14
3Y Avg
1.20
5Y Avg
1.25
Market Cap
$82.59M
Quick Ratio (Acid-Test)
7.85
TTM Avg
4.70
3Y Avg
2.98
5Y Avg
5.25
Market Cap
$82.53M
Quick Ratio (Acid-Test)
16.14
TTM Avg
3.54
3Y Avg
1.85
5Y Avg
1.85
Market Cap
$82.47M
Quick Ratio (Acid-Test)
3.30
TTM Avg
5.38
3Y Avg
8.10
5Y Avg
12.75
Market Cap
$89.44M
Quick Ratio (Acid-Test)
1.00
TTM Avg
1.24
3Y Avg
1.67
5Y Avg
2.90
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | $85.86M | 7.70 | 10.45 | 13.98 | 18.00 |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $87.27M | 4.50 | 8.19 | 12.95 | 15.06 |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | 7.03 | 3.05 | 3.90 | 4.20 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $87.85M | 1.98 | 0.61 | 1.40 | 2.59 |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 1.01 | 1.14 | 1.20 | 1.25 |
| ProMIS Neurosciences, Inc. (PMN)vs › | $82.59M | 7.85 | 4.70 | 2.98 | 5.25 |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $82.53M | 16.14 | 3.54 | 1.85 | 1.85 |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | 3.30 | 5.38 | 8.10 | 12.75 |
| electroCore, Inc. (ECOR)vs › | $89.44M | 1.00 | 1.24 | 1.67 | 2.90 |
| LENSAR Inc (LNSR)vs › | $82.29M | 1.13 | 1.33 | 1.81 | 2.82 |
Quick Ratio
7.70
Excludes inventory
Current Ratio
7.70
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 7.70 |
| 2026-03-31 | 11.14 |
| 2025-12-31 | 10.09 |
| 2025-09-30 | 10.76 |
| 2025-06-30 | 12.52 |
| 2025-03-31 | 16.75 |
| 2024-12-31 | 12.22 |
| 2024-09-30 | 13.98 |
| 2024-06-30 | 19.22 |
| 2024-03-31 | 16.79 |
| 2023-12-31 | 14.78 |
| 2023-09-30 | 19.16 |
| 2023-06-30 | 16.63 |
| 2023-03-31 | 22.03 |
| 2022-12-31 | 22.80 |
| 2022-09-30 | 22.75 |
| 2022-06-30 | 24.76 |
| 2022-03-31 | 24.65 |
| 2021-12-31 | 24.66 |
| 2021-09-30 | 36.62 |
| 2021-06-30 | 43.05 |
| 2021-03-31 | 57.79 |
| 2020-12-31 | 56.90 |
| 2020-09-30 | 68.24 |
| 2020-06-30 | 17.07 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 22.57 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
